| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $235.2M | +0.3% |
| Cost of Revenue | $145.6M | +22.8% |
| Gross Profit | $89.7M | -22.7% |
| R&D Expense | $138.1M | +49.8% |
| SG&A Expense | $139.1M | +8.0% |
| Operating Income | -$746.2M | -278.3% |
| Interest Expense | $24.8M | +119.8% |
| Pre-tax Income | -$766.1M | -268.2% |
| Income Tax | -$2.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.2M | -41.7% |
| Short-term Investments | $229.9M | -31.2% |
| Accounts Receivable | $22.7M | -33.3% |
| Current Assets | $396.1M | -35.4% |
| Total Assets | $432.8M | -61.1% |
| Current Liabilities | $35.5M | -40.9% |
| Long-term Debt | $216.8M | +1.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$190.4M | -49.3% |
| Investing Cash Flow | $99.4M | +115.7% |
| Financing Cash Flow | $2.2M | -99.8% |
| +94.2% |
| Net Income | -$720.2M | -323.8% |
| EPS (Basic) | -$3.28 | -152.3% |
| EPS (Diluted) | -$3.28 | -152.3% |
| Total Liabilities |
| $268.8M |
| -10.9% |
| Stockholders' Equity | $123.2M | -84.1% |